openPR Logo
Press release

Next Generation Cancer Diagnostic Devices Market Report Analysis, Research Studies | GE Healthcare, Siemens Healthineers & Philips Healthcare.

09-04-2024 12:05 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Next Generation Cancer Diagnostic Devices Market || 2024-2031

Next Generation Cancer Diagnostic Devices Market || 2024-2031

The Next Generation Cancer Diagnostic Devices Market is projected to grow at a robust CAGR of 18% from 2024 to 2031.

Cancer diagnostics involves detecting various biomarkers, proteins, and specific symptoms to identify cancerous tumors in patients. This process relies heavily on advanced technologies and devices specifically designed for cancer diagnosis. Cancer diagnostic devices are primarily categorized into genomics, proteomics, metabolomics, epigenetics, instrument-based methods, and tumor biomarker tests. According to the National Cancer Institute, approximately 2 million cancer cases were diagnosed in the United States in 2018, with nearly 609,640 projected deaths due to cancer.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/next-generation-cancer-diagnostic-devices-market

Market Dynamics:

The increasing incidence of cancer cases is expected to drive the global next-generation cancer diagnostic device market during the forecast period.

According to the World Health Organization (WHO), cancer is the second leading cause of death globally, with over 18.1 million cases diagnosed in 2018. The most common cancers in the U.S. include lung, breast, prostate, colorectal, thyroid, pancreatic cancer, non-Hodgkin lymphoma, melanoma, renal pelvis cancer, kidney cancer, and leukemia. In 2020, approximately 19 million new cancer cases were diagnosed worldwide, according to WHO, while the American Cancer Society reported 89,500 new cases in the U.S. This surge has driven the adoption of cancer diagnostic devices.

The number of advanced research projects in oncology and preventive diagnosis is expected to boost the global next-generation cancer diagnostic market. Advances in diagnostic imaging techniques have significantly increased the demand for cancer diagnostics. Imaging has become a crucial element of cancer detection, particularly for breast, lung, prostate, and colorectal cancers. For instance, in 2018, Toshiba Medical Systems Corporation introduced MicroPure ultrasound technology for early detection of microcalcification in breast tissue. Additionally, evolving PET camera technology and the integration of PET/CT have enhanced diagnostic accuracy by providing simultaneous morphological and functional information, further driving market growth.

Market Segmentation:

By Test Type: Liquid Biopsy, Imaging Tests, Tumour Biomarkers Tests, Insitu Hybridization, Immunohistochemistry, Others.

By Cancer Type: Lung Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, Kidney Cancer, Others.

By End-user : Hospital associated labs, Cancer research institutes, Diagnostic imaging centres, Diagnostic laboratories.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/next-generation-cancer-diagnostic-devices-market

Competitive Landscape:

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Biocartis
• Becton
• Abbott laboratories
• Hoffman-La Roche AG
• Dickinson and Company
• Thermo Fischer Scientific
• Sysmex Corporation

Product Portfolio:

Company Overview: GE Healthcare is an American multinational conglomerate headquartered in Chicago, Illinois, and incorporated in New York. Since 2017, the company has been a leading manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals used in medical imaging procedures. GE Healthcare provides a wide range of imaging modalities, including advanced technologies in magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and nuclear medicine, positioning itself as a key player in the global healthcare sector.

Regional Analysis:

The global Next Generation Cancer Diagnostic Devices Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Next Generation Cancer Diagnostic Devices Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Related Reports:

IVD quality control Market: https://datamintelligence.com/research-report/ivd-quality-control-market

Hydrocephalus Shunts Market: https://datamintelligence.com/research-report/hydrocephalus-shunts-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next Generation Cancer Diagnostic Devices Market Report Analysis, Research Studies | GE Healthcare, Siemens Healthineers & Philips Healthcare. here

News-ID: 3645016 • Views:

More Releases from DataM Intelligence 4market Research LLP

Biomass Gasification Technology Market to Reach USD 68.56 Million by 2032 at 8.9% CAGR, Led by Agricultural Residues (35%) and North America (30% Share), with Thyssenkrupp & Air Liquide Driving AI-Optimized Syngas & Renewable Power Solutions
Biomass Gasification Technology Market to Reach USD 68.56 Million by 2032 at 8.9 …
The Biomass Gasification Technology Market reached US$ 34.66 million in 2024 and is expected to grow to around US$ 68.56 million by 2032, expanding at a CAGR of approximately 8.9 % from 2025 to 2032 as renewable energy adoption accelerates and biomass conversion technologies gain prominence globally. Growth is supported by increasing demand across key applications such as renewable power generation, industrial heat production, waste‐to‐energy conversion, and biofuel & syngas production,
Defense Cybersecurity Market to Reach USD 66.89 Billion by 2032 at 7.6% CAGR, Led by Software Solutions (40%) and North America (40% Share), with Northrop Grumman & Lockheed Martin Driving AI-Powered Threat Defense & Zero-Trust Adoption
Defense Cybersecurity Market to Reach USD 66.89 Billion by 2032 at 7.6% CAGR, Le …
The Defense Cybersecurity Market reached US$ 37.23 billion in 2024 and is expected to grow to approximately US$ 66.89 billion by 2032, expanding with a CAGR of about 7.6 % from 2025 to 2032 as governments and military organizations worldwide escalate investments to protect critical defense infrastructure and sensitive data from evolving cyber threats. Growth is supported by increasing demand across key areas such as secure communications, threat detection & response,
EV Charging Smart Grids Market to Reach US$ 10.1 Billion by 2030 Growing at 30.0% CAGR Driven by Rising EV Adoption, V2G Integration, and Smart Grid Modernization
EV Charging Smart Grids Market to Reach US$ 10.1 Billion by 2030 Growing at 30.0 …
The EV Charging Smart Grids Market reached US$ 1.2 billion in 2022 and is expected to reach US$ 10.1 billion by 2030, growing at a remarkable CAGR of 30.0% during the forecast period 2024-2031. Growth is driven by the rapid expansion of electric vehicle adoption, increasing pressure on conventional power grids, and the need for intelligent energy management systems. EV charging smart grids enable real-time load balancing, demand response, vehicle-to-grid (V2G)
Global Natural Antioxidants Market Witnessing Rising Demand in Food & Personal Care Sectors, Driven by Clean-Label Trends | Key Players - BASF SE, DSM N.V, Archer Daniels Midland
Global Natural Antioxidants Market Witnessing Rising Demand in Food & Personal C …
Natural Antioxidants Market Size and Forecast Natural Antioxidants Market is growing at a CAGR of 5.5% % in the forecast period (2024-2031) DataM Intelligence has published a new research report on "Natural Antioxidants Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For